Oral deferiprone--controversies on its efficacy and safety.
Choudhry
V P
VP
Department of Hematology, All India Institute of Medical Sciences, New Delhi.
D002648:Child; D002986:Clinical Trials as Topic; D000077543:Deferiprone; D003906:Developing Countries; D006580:Genetic Carrier Screening; D006801:Humans; D007194:India; D007502:Iron Chelating Agents / Q000008:administration & dosage* / Q000009:adverse effects; D011728:Pyridones / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D017086:beta-Thalassemia / Q000188:drug therapy* / Q000235:genetics
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone